BMS-813160 T4584
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
BMS-813160 is the first dual�CCR2/CCR5�antagonist to enter Clinical development for cardiovascular.
CAS nr:
1286279-29-5
Purity:
98%
Molecular Weight:
484,64
SMILES:
CC(C)(C)N[C@@H]1CC[C@@H]([C@H](NC(C)=O)C1)N4CC[C@H](Nc2ncnc3cc(nn23)C(C)(C)C)C4=O
Formula:
C25H40N8O2
Pathway:
Microbiology/Virology,Immunology/Inflammation
Target:
CCR,CCR
